ReviewCurrent atherosclerosis reports2022

Updates on the Use of Subclinical Atherosclerosis to Predict Risk of Cardiovascular Events in Heterozygous Familial Hypercholesterolemia.

Antonio Gallo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.